Archives

by in
Entry Author Date Location
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
VoloMetrix Raises $12M to Market ‘People Analytics’ Software 10/13/14 Seattle
Texas Medical Center Makes Pitch to Boost Houston Biotech Startups 10/07/14 Texas
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Google’s Calico Nabs First Partner, Cuts $1.5B R&D Deal With AbbVie 09/03/14 San Francisco
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
NJ’s Medicine Chest Thins Again as GE Health Unit Heads for MA 08/19/14 Boston
West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More 08/14/14 San Francisco
While Protesters Rage Against Tech Giants, Biotech Drives Quietly By 08/12/14 National
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Avalanche Bio Rolls Onto Nasdaq After Upsized, $102M IPO 07/31/14 San Francisco
To Solve Alzheimer’s Mystery, Better Biological Clues Sorely Needed 07/29/14 National
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma 07/02/14 San Diego
Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics 07/01/14 Boston
Langer, Led Zeppelin, and Hookups: Three Days Behind the BIO Scenes 06/27/14 San Diego
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
ZS Pharma Ends Texas Biotech IPO Dry Spell With $86M Pitch 05/20/14 Texas
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
Just 7 Tickets Left for Our What’s Hot in Cancer Event April 22 04/21/14 Seattle
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Cerulean Limps into Nasdaq Debut With $7 Per Share IPO 04/10/14 Boston
Page 1 of 16 next page »